Neuren Pharmaceuticals Limited ( (AU:NEU) ) has shared an announcement.
Neuren Pharmaceuticals Limited has announced an update on its ongoing share buy-back program, reporting the purchase of 40,905 ordinary fully paid securities on the previous day. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value.
More about Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development of therapies for neurodevelopmental disorders. The company is listed on the Australian Securities Exchange under the code NEU.
YTD Price Performance: -11.60%
Average Trading Volume: 720
Technical Sentiment Signal: Buy
Current Market Cap: $1.01B
Learn more about NEU stock on TipRanks’ Stock Analysis page.